Market expert Raja Venkatraman, co-founder of NeoTrader, has shared his trading recommendations and technical outlook for the market session on 11 November 2026. Following a period of consolidation characterized by subtle underlying volatility, Indian equities experienced renewed directional conviction. The trading week opened on a positive trajectory as benchmark indices registered solid gains, with the BSE Sensex advancing 107.25 points to finish at 81,106.65, while the NSE Nifty gained 58.25 points, or 0.23 percent, settling at 25,044.65.

Trading activity was temporarily paused on Tuesday due to the Diwali-Balipratipada market holiday, setting the stage for traders to reposition ahead of the remaining sessions. Venkatraman highlighted that previous gradual market swings have shifted toward stronger momentum, prompting specific stock-level opportunities. With key indices navigating vital benchmarks, market participants are closely monitoring technical structures and levels across prominent corporate names as the broader exchange attempts to extend its opening rally.

Among the primary picks highlighted by the analyst is Mankind Pharma Ltd, trading at a market price of ₹2,668.30. The pharmaceutical player ranks among the top four domestic drugmakers by sales and holds the leading position in prescription volume across India. Although lack of upward traction had subjected the shares to a prolonged declining phase testing major support zones since May 2026, recent price action indicates emerging stability for traders.